Denosumab Solution For Injection

Name: Denosumab Solution For Injection
Brand: NEETCO BIOPHARMA
Price: 21999 INR
Availability: InStock

Price 21999 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Denosumab Solution For Injection Specification

Pacakaging (Quantity Per Box)
Single vial per box

Origin of Medicine
Allopathic

Dosage Form
Injectable Solution

Salt Composition
Denosumab 60 mg

Indication
Treatment of osteoporosis and bone loss

Drug Type
Biological

Ingredients
Denosumab

Physical Form
Solution For Injection

Function
Prevents bone loss and fractures

Recommended For
Postmenopausal women with osteoporosis, patients at increased risk of fractures

Dosage
As prescribed by physician

Dosage Guidelines
Administered subcutaneously every 6 months or as directed by physician

Suitable For
Adults

Quantity
1 Vial (60 mg/1 ml)

Storage Instructions
Store in refrigerator (2C 8C). Do not freeze.

About Denosumab Solution For Injection

Experience the prodigious effectiveness of Denosumab Solution for Injection, marketed under grand names like Prolia and Xgeva. This allopathic, lustrous solution delivers affordable and special care for postmenopausal women battling osteoporosis and patients at increased risk of fractures. Each single vial contains 60 mg/1 ml of Denosumab, administered via subcutaneous injection every six months as prescribed by your physician. With a generous shelf life of 24 months, this bargain solution is clear, colorless to pale yellow, and must be refrigerated. Strictly for adult use and administered under medical supervision only.

Advantage and Application of Denosumab Injection

Denosumab Solution for Injection offers significant advantage by effectively preventing bone loss and fractures, especially in postmenopausal women and high-risk individuals. The application surface is subcutaneous tissue, with common sites being the upper arm, thigh, or abdomen. This solution is particularly beneficial for adults requiring potent bone-strengthening therapy. Denosumab is administered every six months by a healthcare professional, ensuring convenient and sustained effect for those seeking reliable osteoporosis management.

Packaging, Supply, and Sample Policy Information

Denosumab Solution is carefully packaged-each purchase order is fulfilled with a single vial per box, ensuring patient safety and maintaining product integrity. Supply ability is robust, supported by dependable distributor and exporter networks, primarily from India. Upon receiving your purchase order, products are promptly dispatched and securely handed over to logistics partners. Sample policy details are available upon request for qualified institutions, reflecting our commitment to providing high-quality, authenticated medical products.

FAQ's of Denosumab Solution For Injection:

Q: How should Denosumab Solution for Injection be stored?

A: Denosumab Solution must be stored in a refrigerator at 2C to 8C. It should never be frozen, and it must be kept out of reach of children.

Q: What is the process for Denosumab administration?

A: Denosumab is administered as a subcutaneous injection, typically given in the upper arm, thigh, or abdomen. It is injected by a healthcare professional every six months or as prescribed.

Q: When can patients expect to see the benefits of Denosumab therapy?

A: Improvement in bone density and reduction in fracture risk can generally be observed over several months with regular Denosumab therapy, depending on individual health profiles.

Q: Where can I purchase Denosumab Solution for Injection?

A: Denosumab Solution is available through licensed distributors, exporters, suppliers, and traders, particularly in India. A valid prescription is required for purchase.

Q: What precautions should be taken before using Denosumab?

A: Denosumab should only be used under medical supervision. Inform your doctor about any medical conditions and current medications. It is not recommended for use in children or those with low calcium levels.

Q: Why is Denosumab considered a special solution for osteoporosis?

A: Denosumab is a targeted biological agent that significantly reduces bone resorption and fracture risk, offering a potent and distinct therapy compared to traditional osteoporosis treatments.

Tell us about your requirement